34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene

C200H112N16 — CID 160501092

IUPAC34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene
SMILESc1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c3c3c2c2ccccc2cc3n2c3ccccc3c3cc5ccccc5c4c32)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7c8ccccc8c8ccccc8c7n(c7cccc2c7c43)c56)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7cc8ccccc8cc7n(c56)c5c6ccccc6cc2c5c43)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7cc8ccccc8cc7n(c7cc8ccccc8c2c7c43)c56)cc1
InChIInChI=1S/4C50H28N4/c1-2-14-30(15-3-1)46-50(52-47-34-19-8-4-13-29(34)25-26-39(47)51-46)54-41-24-12-22-37-43-33-18-7-5-16-31(33)27-38-36-21-10-11-23-40(36)53(49(38)43)42-28-32-17-6-9-20-35(32)48(54)45(42)44(37)41;1-2-14-30(15-3-1)46-50(52-47-31-16-5-4-13-29(31)27-28-39(47)51-46)53-40-24-11-21-35-37-22-10-23-38-43-34-19-8-6-17-32(34)33-18-7-9-20-36(33)49(43)54(48(37)38)42-26-12-25-41(53)45(42)44(35)40;1-2-13-30(14-3-1)46-50(52-47-34-18-8-6-12-29(34)24-25-40(47)51-46)54-41-23-11-20-36-37-21-10-22-38-39-26-31-15-4-5-16-32(31)27-42(39)53(48(37)38)43-28-33-17-7-9-19-35(33)49(54)45(43)44(36)41;1-2-13-30(14-3-1)46-50(52-47-34-18-8-6-12-29(34)24-25-40(47)51-46)53-41-23-11-20-36-37-21-10-22-38-39-26-31-15-4-5-16-32(31)27-42(39)54(48(37)38)49-35-19-9-7-17-33(35)28-43(53)45(49)44(36)41/h4*1-28H
InChIKeyQRUDRWAJEXIGIN-UHFFFAOYSA-N
MW2739.21 g/mol
LogP52.01
Rot. Bonds8

About 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene

34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene (PubChem CID 160501092) has the molecular formula C200H112N16 and a molecular weight of 2739.21 g/mol. Its IUPAC name is 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene.

Molecular Properties

Compound Name34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene
PubChem CID160501092
Molecular FormulaC200H112N16
Molecular Weight2739.21 g/mol
Exact Mass2736.93
IUPAC Name34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene
SMILESc1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c3c3c2c2ccccc2cc3n2c3ccccc3c3cc5ccccc5c4c32)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7c8ccccc8c8ccccc8c7n(c7cccc2c7c43)c56)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7cc8ccccc8cc7n(c56)c5c6ccccc6cc2c5c43)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7cc8ccccc8cc7n(c7cc8ccccc8c2c7c43)c56)cc1
InChIInChI=1S/4C50H28N4/c1-2-14-30(15-3-1)46-50(52-47-34-19-8-4-13-29(34)25-26-39(47)51-46)54-41-24-12-22-37-43-33-18-7-5-16-31(33)27-38-36-21-10-11-23-40(36)53(49(38)43)42-28-32-17-6-9-20-35(32)48(54)45(42)44(37)41;1-2-14-30(15-3-1)46-50(52-47-31-16-5-4-13-29(31)27-28-39(47)51-46)53-40-24-11-21-35-37-22-10-23-38-43-34-19-8-6-17-32(34)33-18-7-9-20-36(33)49(43)54(48(37)38)42-26-12-25-41(53)45(42)44(35)40;1-2-13-30(14-3-1)46-50(52-47-34-18-8-6-12-29(34)24-25-40(47)51-46)54-41-23-11-20-36-37-21-10-22-38-39-26-31-15-4-5-16-32(31)27-42(39)53(48(37)38)43-28-33-17-7-9-19-35(33)49(54)45(43)44(36)41;1-2-13-30(14-3-1)46-50(52-47-34-18-8-6-12-29(34)24-25-40(47)51-46)53-41-23-11-20-36-37-21-10-22-38-39-26-31-15-4-5-16-32(31)27-42(39)54(48(37)38)49-35-19-9-7-17-33(35)28-43(53)45(49)44(36)41/h4*1-28H
InChIKeyQRUDRWAJEXIGIN-UHFFFAOYSA-N
XLogP52.01
TPSA140.48 Ų
H-Bond Donors
H-Bond Acceptors16
Rotatable Bonds8
Heavy Atoms216
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002739.21
LogP ≤ 552.01
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1016

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Polycyclic_aromatic_hydrocarbon_3', 'substructure': 'N/A'}

Analyze 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene?
The IUPAC name of 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene (CID 160501092) is 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene.
What is the SMILES notation for 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene?
The canonical SMILES for 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene is c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c3c3c2c2ccccc2cc3n2c3ccccc3c3cc5ccccc5c4c32)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7c8ccccc8c8ccccc8c7n(c7cccc2c7c43)c56)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7cc8ccccc8cc7n(c56)c5c6ccccc6cc2c5c43)cc1.c1ccc(-c2nc3ccc4ccccc4c3nc2-n2c3cccc4c5cccc6c7cc8ccccc8cc7n(c7cc8ccccc8c2c7c43)c56)cc1.
What is the InChIKey of 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene?
The InChIKey is QRUDRWAJEXIGIN-UHFFFAOYSA-N. The full InChI is InChI=1S/4C50H28N4/c1-2-14-30(15-3-1)46-50(52-47-34-19-8-4-13-29(34)25-26-39(47)51-46)54-41-24-12-22-37-43-33-18-7-5-16-31(33)27-38-36-21-10-11-23-40(36)53(49(38)43)42-28-32-17-6-9-20-35(32)48(54)45(42)44(37)41;1-2-14-30(15-3-1)46-50(52-47-31-16-5-4-13-29(31)27-28-39(47)51-46)53-40-24-11-21-35-37-22-10-23-38-43-34-19-8-6-17-32(34)33-18-7-9-20-36(33)49(43)54(48(37)38)42-26-12-25-41(53)45(42)44(35)40;1-2-13-30(14-3-1)46-50(52-47-34-18-8-6-12-29(34)24-25-40(47)51-46)54-41-23-11-20-36-37-21-10-22-38-39-26-31-15-4-5-16-32(31)27-42(39)53(48(37)38)43-28-33-17-7-9-19-35(33)49(54)45(43)44(36)41;1-2-13-30(14-3-1)46-50(52-47-34-18-8-6-12-29(34)24-25-40(47)51-46)53-41-23-11-20-36-37-21-10-22-38-39-26-31-15-4-5-16-32(31)27-42(39)54(48(37)38)49-35-19-9-7-17-33(35)28-43(53)45(49)44(36)41/h4*1-28H.
What are the key properties of 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene?
34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene has a molecular weight of 2739.21 g/mol, XLogP of 52.01, 8 rotatable bonds, 0 hydrogen bond donors, and 16 hydrogen bond acceptors.
Where does this data come from?
All data for 34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.16,9.02,7.08,13.014,33.019,32.020,25.026,31]tetratriaconta-2,4,6,8(13),9,11,14(33),15,17,19(32),20,22,24,26,28,30-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.03,8.012,17.022,33.023,32.025,30]tetratriaconta-2(11),3,5,7,9,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.019,24.026,33.027,32]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene;34-(3-phenylbenzo[h]quinoxalin-2-yl)-1,34-diazanonacyclo[16.14.1.110,13.02,11.04,9.012,17.022,33.023,32.025,30]tetratriaconta-2,4,6,8,10,12(17),13,15,18(33),19,21,23,25,27,29,31-hexadecaene is sourced from PubChem (CID 160501092), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).